Takara Bio Inc. (TYO:4974)

Takara Bio Statistics

Total Valuation

Takara Bio has a market cap or net worth of JPY 138.00 billion. The enterprise value is 128.44 billion.

Market Cap	138.00B
Enterprise Value	128.44B

Important Dates

The last earnings date was Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Takara Bio has 120.42 million shares outstanding.

Current Share Class	120.42M
Shares Outstanding	120.42M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	0.56%
Owned by Institutions (%)	9.39%
Float	44.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.13
PB Ratio	1.36
P/TBV Ratio	1.79
P/FCF Ratio	n/a
P/OCF Ratio	32.65
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 32.27, with an EV/FCF ratio of -15.32.

EV / Earnings	-17.84
EV / Sales	2.91
EV / EBITDA	32.27
EV / EBIT	n/a
EV / FCF	-15.32

Financial Position

The company has a current ratio of 5.47, with a Debt / Equity ratio of 0.10.

Current Ratio	5.47
Quick Ratio	3.58
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	-1.19
Interest Coverage	-2.66

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-1.24%
Return on Capital Employed (ROCE)	-0.92%
Weighted Average Cost of Capital (WACC)	6.82%
Revenue Per Employee	24.82M
Profits Per Employee	-4.05M
Employee Count	1,779
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Takara Bio has paid 1.55 billion in taxes.

Income Tax	1.55B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +36.11% in the last 52 weeks. The beta is 0.51, so Takara Bio's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	+36.11%
50-Day Moving Average	897.94
200-Day Moving Average	870.95
Relative Strength Index (RSI)	84.21
Average Volume (20 Days)	1,055,605

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Takara Bio had revenue of JPY 44.15 billion and -7.20 billion in losses. Loss per share was -59.79.

Revenue	44.15B
Gross Profit	23.84B
Operating Income	-1.13B
Pretax Income	-5.60B
Net Income	-7.20B
EBITDA	3.98B
EBIT	-1.13B
Loss Per Share	-59.79

Balance Sheet

The company has 19.83 billion in cash and 10.00 billion in debt, with a net cash position of 9.83 billion or 81.65 per share.

Cash & Cash Equivalents	19.83B
Total Debt	10.00B
Net Cash	9.83B
Net Cash Per Share	81.65
Equity (Book Value)	101.33B
Book Value Per Share	839.14
Working Capital	34.95B

Cash Flow

In the last 12 months, operating cash flow was 4.23 billion and capital expenditures -12.61 billion, giving a free cash flow of -8.38 billion.

Operating Cash Flow	4.23B
Capital Expenditures	-12.61B
Free Cash Flow	-8.38B
FCF Per Share	-69.63

Margins

Gross Margin	n/a
Operating Margin	-2.56%
Pretax Margin	-12.68%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 17.00, which amounts to a dividend yield of 1.48%.

Dividend Per Share	17.00
Dividend Yield	1.48%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	1.48%
Earnings Yield	-5.22%
FCF Yield	-6.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 29, 2011. It was a forward split with a ratio of 400.

Last Split Date	Mar 29, 2011
Split Type	Forward
Split Ratio	400

Scores

Altman Z-Score	n/a
Piotroski F-Score	2